Complete Filing Data
Kyverna Therapeutics, Inc. reported Stockholders Equity of $232.28 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Kyverna Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$8.0K | $101.0K | $30.0K |
| Net Income Loss | -$161.3M | -$127.5M | -$60.4M |
| Research And Development Expense | $133.7M | $112.5M | $49.9M |
| Other Nonoperating Income Expense | -$85.0K | -$90.0K | -$55.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$8.0K | $101.0K | $30.0K |
| Operating Income Loss | -$169.8M | -$142.6M | -$62.4M |
| Operating Expenses | $169.8M | $142.6M | $62.4M |
| Nonoperating Income Expense | $8.5M | $15.1M | $2.0M |
| General And Administrative Expense | $36.1M | $30.1M | $12.5M |
| Comprehensive Income Net Of Tax | -$161.3M | -$127.4M | -$60.3M |
| Interest Expense Nonoperating | $489.0K | $142.0K | $187.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $49.0K | -$19.0K | -$106.0K | $190.0K | -$36.0K | -$5.0K | $5.0K | $8.0K | $18.0K |
| Net Income Loss | -$36.8M | -$42.1M | -$44.6M | -$34.5M | -$28.8M | -$26.7M | -$15.5M | -$13.1M | -$11.1M |
| Research And Development Expense | $30.5M | $35.8M | $37.4M | $29.2M | $27.3M | $22.5M | $13.6M | $10.4M | $8.7M |
| Other Nonoperating Income Expense | -$53.0K | -$21.0K | -$27.0K | -$45.0K | -$23.0K | -$26.0K | -$13.0K | -$7.0K | -$3.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $49.0K | -$19.0K | -$106.0K | $190.0K | -$36.0K | -$5.0K | $5.0K | $8.0K | $18.0K |
| Operating Income Loss | -$38.7M | -$44.4M | -$47.4M | -$38.8M | -$33.4M | -$29.4M | -$16.3M | -$13.3M | -$11.4M |
| Operating Expenses | $38.7M | $44.4M | $47.4M | $38.8M | $33.4M | $29.4M | $16.3M | $13.3M | $11.4M |
| Nonoperating Income Expense | $1.9M | $2.3M | $2.8M | $4.3M | $4.6M | $2.7M | $817.0K | $211.0K | $302.0K |
| General And Administrative Expense | $8.3M | $8.6M | $10.0M | $9.6M | $6.1M | $6.9M | $2.6M | $2.9M | $2.7M |
| Comprehensive Income Net Of Tax | -$36.7M | -$42.1M | -$44.7M | -$34.3M | -$28.8M | -$26.7M | -$15.5M | -$13.1M | -$11.1M |
| Interest Expense Nonoperating | $7.0K | $14.0K | $25.0K | $32.0K | $39.0K | $44.0K | $50.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $232.3M | $266.6M | -$13.1M | -$74.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $124.6M | $97.2M | $35.2M | $38.3M |
| Cash And Cash Equivalents At Carrying Value | $124.1M | $96.6M | $34.6M | |
| Finance Lease Principal Payments | $808.0K | $956.0K | $781.0K | |
| Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability | $194.0K | $2.5M | $975.0K | |
| Retained Earnings Accumulated Deficit | -$424.8M | -$263.5M | -$136.0M | |
| Restricted Cash Noncurrent | $551.0K | $552.0K | $565.0K | |
| Restricted Cash Current | $551.0K | $552.0K | $565.0K | |
| Property Plant And Equipment Net | $1.5M | $3.3M | $2.3M | |
| Prepaid Expense And Other Assets Current | $3.7M | $4.6M | $3.1M | |
| Other Assets Noncurrent | $4.9M | $2.8M | $3.4M | |
| Other Accrued Expenses And Current Liabilities | $13.5M | $14.1M | $3.5M | |
| Operating Lease Right Of Use Asset | $3.6M | $6.5M | $6.5M | |
| Operating Lease Liability Noncurrent | $320.0K | $4.2M | $5.2M | |
| Operating Lease Liability Current | $3.7M | $3.2M | $2.0M | |
| Non Cash Vesting Of Restricted Stock | $0.00 | $6.0K | $71.0K | |
| Non Cash Lease Expense | $2.9M | $2.5M | $1.7M | |
| Marketable Securities Current | $155.2M | $189.4M | $22.9M | |
| Liabilities Current | $36.5M | $33.8M | $19.9M | |
| Liabilities And Stockholders Equity | $293.8M | $304.6M | $75.2M | |
| Liabilities | $61.6M | $38.1M | $26.0M | |
| Finance Lease Right Of Use Asset | $305.0K | $841.0K | $1.8M | |
| Finance Lease Liability Noncurrent | $0.00 | $142.0K | $921.0K | |
| Finance Lease Liability Current | $307.0K | $779.0K | $956.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $27.5M | $62.0M | -$3.1M | |
| Assets Current | $283.0M | $290.6M | $60.7M | |
| Assets | $293.8M | $304.6M | $75.2M | |
| Additional Paid In Capital Common Stock | $657.0M | $530.0M | $4.6M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $97.0K | $105.0K | $4.0K | |
| Accrued License Expense Related Party | $3.8M | $6.3M | $6.3M | |
| Accrued Employee Benefits Current | $10.0M | $4.9M | $2.8M | |
| Accretion Amortization Of Discounts And Premiums Investments | $6.9M | $7.7M | $1.1M | |
| Accounts Payable Current | $5.3M | $4.6M | $4.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $151.9M | $184.4M | $224.0M | $302.7M | $333.5M | $361.0M | -$111.8M | -$97.2M | -$84.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $34.7M | $54.0M | $57.4M | $105.2M | $132.2M | $224.9M | $23.5M | $54.0M | $40.3M |
| Cash And Cash Equivalents At Carrying Value | $34.2M | $53.4M | $56.9M | $104.7M | $131.6M | $224.3M | $23.0M | $53.4M | $39.8M |
| Finance Lease Principal Payments | $341.0K | $241.0K | $245.0K | $231.0K | $206.0K | $187.0K | $168.0K | ||
| Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability | $0.00 | $2.5M | $357.0K | ||||||
| Retained Earnings Accumulated Deficit | -$387.0M | -$350.2M | -$308.2M | -$226.0M | -$191.5M | -$162.7M | |||
| Restricted Cash Noncurrent | $551.0K | $551.0K | $557.0K | $564.0K | $574.0K | $570.0K | |||
| Restricted Cash Current | $551.0K | $551.0K | $557.0K | $564.0K | $574.0K | $570.0K | $561.0K | $558.0K | $556.0K |
| Property Plant And Equipment Net | $1.8M | $2.2M | $2.4M | $3.2M | $3.4M | $2.7M | |||
| Prepaid Expense And Other Assets Current | $3.8M | $2.7M | $5.0M | $3.8M | $2.6M | $5.7M | |||
| Other Assets Noncurrent | $5.4M | $4.1M | $3.6M | $1.9M | $1.2M | $1.2M | |||
| Other Accrued Expenses And Current Liabilities | $14.0M | $15.1M | $11.9M | $6.4M | $5.8M | $3.1M | |||
| Operating Lease Right Of Use Asset | $4.3M | $5.0M | $5.8M | $7.2M | $7.8M | $8.5M | |||
| Operating Lease Liability Noncurrent | $1.3M | $2.3M | $3.3M | $5.0M | $5.7M | $6.5M | |||
| Operating Lease Liability Current | $3.5M | $3.3M | $3.1M | $3.0M | $2.9M | $2.7M | |||
| Non Cash Vesting Of Restricted Stock | $0.00 | $6.0K | $18.0K | ||||||
| Non Cash Lease Expense | $704.0K | $526.0K | $384.0K | ||||||
| Marketable Securities Current | $137.0M | $158.2M | $185.8M | $216.9M | $214.6M | $145.5M | |||
| Liabilities Current | $33.9M | $39.8M | $33.3M | $31.0M | $23.5M | $21.9M | |||
| Liabilities And Stockholders Equity | $187.2M | $226.5M | $260.7M | $339.2M | $363.1M | $390.0M | |||
| Liabilities | $35.2M | $42.1M | $36.6M | $36.5M | $29.6M | $29.0M | |||
| Finance Lease Right Of Use Asset | $212.0K | $366.0K | $603.0K | $1.1M | $1.3M | $1.6M | |||
| Finance Lease Liability Noncurrent | $8.0K | $26.0K | $73.0K | $237.0K | $407.0K | $667.0K | |||
| Finance Lease Liability Current | $190.0K | $292.0K | $507.0K | $931.0K | $1.0M | $979.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$39.8M | $189.6M | $2.1M | ||||||
| Assets Current | $174.9M | $214.3M | $247.7M | $325.4M | $348.8M | $375.5M | |||
| Assets | $187.2M | $226.5M | $260.7M | $339.2M | $363.1M | $390.0M | |||
| Additional Paid In Capital Common Stock | $538.9M | $534.6M | $532.2M | $528.6M | $525.1M | $523.7M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $29.0K | -$20.0K | -$1.0K | $153.0K | -$37.0K | -$1.0K | |||
| Accrued License Expense Related Party | $6.3M | $6.3M | $6.3M | $6.3M | $6.3M | $6.3M | |||
| Accrued Employee Benefits Current | $7.0M | $5.0M | $3.1M | $4.4M | $2.7M | $1.4M | |||
| Accretion Amortization Of Discounts And Premiums Investments | $2.1M | $280.0K | $78.0K | ||||||
| Accounts Payable Current | $3.0M | $9.9M | $8.5M | $9.9M | $4.9M | $7.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $10.1M | $8.4M | $2.2M |
| Proceeds From Stock Options Exercised | $2.0M | $259.0K | $645.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $405.7M | $331.3M | $46.7M |
| Payments To Acquire Property Plant And Equipment | $5.0K | $2.2M | $621.0K |
| Net Cash Provided By Used In Operating Activities | -$153.7M | -$114.3M | -$52.4M |
| Net Cash Provided By Used In Investing Activities | $40.0M | -$160.9M | -$8.8M |
| Net Cash Provided By Used In Financing Activities | $141.2M | $337.1M | $58.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$893.0K | $1.5M | $1.2M |
| Increase Decrease In Other Noncurrent Assets | $980.0K | $2.0M | $1.8M |
| Increase Decrease In Other Accrued Expenses And Current Liabilities | -$800.0K | $10.9M | $2.7M |
| Increase Decrease In Operating Lease Liability | -$3.3M | -$2.4M | -$1.7M |
| Increase Decrease In Employee Related Liabilities | $5.1M | $2.1M | $1.4M |
| Increase Decrease In Accounts Payable | $543.0K | $736.0K | $4.1M |
| Depreciation Depletion And Amortization | $1.8M | $2.1M | $1.7M |
| Payments To Acquire Marketable Securities | $364.6M | $490.0M | $54.8M |
| Payments Of Stock Issuance Costs | $475.0K | $3.4M | $1.6M |
| Proceeds From Issuance Initial Public Offering | $99.0M | $341.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Share Based Compensation | $2.2M | $2.3M | $468.0K |
| Proceeds From Stock Options Exercised | $3.0K | $64.0K | $24.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $86.7M | $23.0M | $13.7M |
| Payments To Acquire Property Plant And Equipment | $0.00 | $543.0K | $28.0K |
| Net Cash Provided By Used In Operating Activities | -$44.9M | -$25.5M | -$11.5M |
| Net Cash Provided By Used In Investing Activities | $5.6M | -$122.9M | $13.7M |
| Net Cash Provided By Used In Financing Activities | -$414.0K | $338.0M | -$144.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $380.0K | $2.6M | $161.0K |
| Increase Decrease In Other Noncurrent Assets | $515.0K | $293.0K | $435.0K |
| Increase Decrease In Other Accrued Expenses And Current Liabilities | -$2.3M | -$71.0K | $126.0K |
| Increase Decrease In Operating Lease Liability | -$963.0K | -$520.0K | -$341.0K |
| Increase Decrease In Employee Related Liabilities | -$1.8M | -$1.4M | -$777.0K |
| Increase Decrease In Accounts Payable | $3.8M | $3.1M | $105.0K |
| Depreciation Depletion And Amortization | $501.0K | $482.0K | $394.0K |
| Payments To Acquire Marketable Securities | $81.1M | $145.3M | |
| Payments Of Stock Issuance Costs | $76.0K | $3.0M | |
| Proceeds From Issuance Initial Public Offering | $0.00 | $341.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 44.3M | 38.3M | 673.6K |
| Weighted Average Number Of Diluted Shares Outstanding | 44.3M | 38.3M | 673.6K |
| Earnings Per Share Diluted | $-3.64 | $-3.33 | $-89.61 |
| Earnings Per Share Basic | $-3.64 | $-3.33 | $-89.61 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 0.00 |
| Common Stock Shares Outstanding | 60.4M | 43.2M | 1.3M |
| Common Stock Shares Issued | 60.4M | 43.2M | 1.3M |
| Common Stock Shares Authorized | 490.0M | 490.0M | 140.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 43.4M | 43.2M | 43.2M | 43.2M | 43.1M | 23.8M | 664.7K | 627.6K | 921.3K |
| Weighted Average Number Of Diluted Shares Outstanding | 43.4M | 43.2M | 43.2M | 43.2M | 43.1M | 23.8M | 664.7K | 627.6K | 921.3K |
| Earnings Per Share Diluted | $-0.85 | $-0.97 | $-1.03 | $-0.80 | $-0.67 | $-1.12 | $-23.27 | $-20.86 | $-12.10 |
| Earnings Per Share Basic | $-0.85 | $-0.97 | $-1.03 | $-0.80 | $-0.67 | $-1.12 | $-23.27 | $-20.86 | $-12.10 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||
| Common Stock Shares Outstanding | 43.8M | 43.2M | 43.2M | 43.2M | 43.1M | 43.1M | |||
| Common Stock Shares Issued | 43.8M | 43.2M | 43.2M | 43.2M | 43.1M | 43.1M | |||
| Common Stock Shares Authorized | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | 490.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.1M | $8.4M | $2.2M | |
| Stock Issued During Period Value Stock Options Exercised | $2.0M | $259.0K | $645.0K | |
| Investment Income Interest | $9.1M | $15.4M | $2.3M | |
| Stock Issued During Period Shares Stock Options Exercised | 600.6K | 467.9K | 349.3K | 349.3K |
| Interest Paid Net | $415.0K | $142.0K | $187.0K | |
| Vesting Of Early Exercised Options And Restricted Stock | $6.0K | $71.0K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $6.6M | $30.7M | $100.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.7M | $2.5M | $2.2M | $3.4M | $1.3M | $2.3M | $521.0K | $447.0K | $468.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.7M | $3.0K | $90.0K | $73.0K | $64.0K | $310.0K | $36.0K | $24.0K | |
| Investment Income Interest | $2.0M | $2.4M | $2.8M | $4.4M | $4.7M | $2.7M | $880.0K | $264.0K | $349.0K |
| Stock Issued During Period Shares Stock Options Exercised | 4.0K | 368.2K | |||||||
| Interest Paid Net | $19.0K | $44.0K | $44.0K | ||||||
| Vesting Of Early Exercised Options And Restricted Stock | $6.0K | $18.0K | $17.0K | $18.0K | |||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $30.7M | $49.0K | $51.0K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.